Hepatic SCD1 activity and diacylglycerol but not ceramide concentrations are increased in the non-alcoholic human fatty liver
- Anna Kotronen (anna.kotronen{at}helsinki.fi)1,2,
- Tuulikki Seppänen-Laakso3,
- Jukka Westerbacka1,
- Tuula Kiviluoto4,
- Johanna T. Arola5,
- Anna-Liisa Ruskeepää3,
- Matej Orešič3 and
- Hannele Yki-Järvinen1
- 1Department of Medicine, Division of Diabetes, Helsinki, Finland
- 2Minerva Medical Research Institute, Helsinki, Finland
- 3VTT Technical Research Centre of Finland, Espoo, FI-02044 VTT, Finland
- 4Department of Surgery, University of Helsinki, Helsinki, Finland
- 5Department of Pathology, University of Helsinki and HUSLAB, Helsinki, Finland
Abstract
Objectives: To determine whether i) hepatic ceramide and diacylglycerol concentrations; ii) SCD1 activity; and iii) the hepatic lipogenic index are increased in the human non-alcoholic fatty liver.
Methods: We studied 16 subjects with (n=8) and without (n=8) histologically determined non-alcoholic fatty liver (NAFL+ and NAFL−) matched for age, gender, and BMI. Hepatic concentrations of lipids and fatty acids were quantitated using ultra performance liquid chromatography coupled to mass spectrometry and gas chromatography.
Results: The absolute (nmol/mg) hepatic concentrations of diacylglycerols but not ceramides were increased in NAFL+ as compared to the NAFL− group. The livers of the NAFL+ group contained proportionally less long-chain polyunsaturated fatty acids as compared to the NAFL− group. Liver fat % was positively related to hepatic stearoyl-CoA desaturase 1 (SCD1) activity index (r=0.70, p=0.003) and the hepatic lipogenic index (r=0.54, p=0.030). Hepatic SCD1 activity index was positively related to the concentrations of diacylglycerols (r=0.71, p=0.002) but not ceramides (r=0.07, NS).
Conclusions: We conclude that diacylglycerols but not ceramides are increased in NAFL. The human fatty liver is also characterized by depletion of long polyunsaturated fatty acids in the liver, and increases in hepatic SCD1 and lipogenic activities.
- Non-alcoholic fatty liver disease
- diacylglycerols
- ceramides
- SCD1
- lipogenesis
- long polyunsaturated fatty acids
Footnotes
-
- Received August 5, 2008.
- Accepted October 17, 2008.
- Copyright © American Diabetes Association











